Back

Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

28 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Inflammatory mechanisms in vascular disease Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)

6 More presentations in this session

Presentation thumbnail
PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial
Ms A. Ondracek (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
Mr J. Bernhard (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Bone-marrow-derived nerve growth factor receptor-positive dendritic cells contribute to the suppression of arterial remodelling via apoptosis
Assistant Professor S. Takashima (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.
Doctor L. Huang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model
Doctor B. Barta (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammatory mechanisms in vascular disease

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
thumbnail
Congress Session
Molecular actions of GLP-1 agonists and incretins
thumbnail
Congress Presentation
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources